Drug Shortage Report for TEVA-SALBUTAMOL STERINEBS P.F.
Report ID | 109626 |
Drug Identification Number | 02173360 |
Brand name | TEVA-SALBUTAMOL STERINEBS P.F. |
Common or Proper name | SALBUTAMOL 2MG/ML NEBS |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | SALBUTAMOL |
Strength(s) | 2MG |
Dosage form(s) | SOLUTION |
Route of administration | INHALATION |
Packaging size | 2.5ml |
ATC code | R03AC |
ATC description | ADRENERGICS, INHALANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-03-25 |
Estimated end date | 2020-06-30 |
Actual end date | 2020-05-27 |
Shortage status | Resolved |
Updated date | 2020-05-29 |
Company comments | Allocating to 100% of our market. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2020-05-29 | French | Compare |
v7 | 2020-05-29 | English | Compare |
v6 | 2020-05-21 | French | Compare |
v5 | 2020-05-21 | English | Compare |
v4 | 2020-05-08 | French | Compare |
v3 | 2020-05-08 | English | Compare |
v2 | 2020-03-26 | French | Compare |
v1 | 2020-03-26 | English | Compare |
Showing 1 to 8 of 8